Teva Pharmaceuticals (NYSE:TEVA) announced today that it appointed Dr. Eric A. Hughes as VP of global R&D and chief medical officer. Hughes’ employment becomes effective Aug. 1, 2022, and he will be based out of Tel Aviv, Israel-based Teva’s U.S. headquarters in Parsippany, New Jersey. Get the full story at our sister site, Drug Delivery Business […]
Personnel Moves
Titan Medical names Cary G. Vance as new president, CEO
Titan Medical (Nasdaq:TMDI) announced that it appointed Cary G. Vance as its new president and CEO. Vance will succeed Titan chair of the board of directors, Paul Cataford, who had served as interim president and CEO since December 2021, when David McNally, who previously held the corner office, resigned. Vance’s appointment was made effective today. […]
ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during […]
Inovio names new chief medical officer
Inovio (Nasdaq:INO) announced today that it appointed Dr. Michael Sumner as its new chief medical officer (CMO). Sumner will oversee Inovio’s clinical-stage pipeline of DNA medicines, global clinical development, clinical operations and biostatistics efforts, along with regulatory affairs, pharmacovigilance and medical affairs. He will also serve on the company’s executive leadership team and report to President […]
Medtronic appoints Pfizer EVP as independent board director
Medtronic (NYSE:MDT) announced today that it appointed Lidia Fonseca to its board of directors as an independent director. Fonseca, who serves as EVP and chief digital and technology officer at Pfizer, will become a director effective today. She will serve on the board’s Compensation Committee and Science and Technology Committee. “We are thrilled to welcome […]
Vivera adds two industry veterans to its technology advisory board
Vivera announced today that it added Robert Massoudi and Bryan Hughes to its technology advisory board. Massoudi and Hughes will support Newport Beach, California-based Vivera in its product and software development initiatives while forging strategic partnerships for Zicoh, the company’s electronic dose-controlled medication delivery system designed to improve prescription drug adherence, including medications with a higher […]
Vektor Medical names Rob Krummen as CEO
Vektor Medical this week announced that it appointed Rob Krummen as CEO. Krummen previously served as president and chief operating officer of the San Diego-based company. He was responsible for the clinical, regulatory, engineering and operations and will continue to oversee the efforts while growing the company’s commercial and sales teams as CEO. The company […]
Owens & Minor appoints Tammy Gomez as chief human resources officer
Owens & Minor (NYSE:OMI) today announced that it has appointed Tammy Gomez as executive VP and chief human resources officer, effective July 11. Gomez will report directly to president and CEO Edward Pesicka and will come a member of the company’s executive leadership team. She will be responsible for teammate strategy and will oversee global […]
Iterative Scopes appoints new chief technology officer
Iterative Scopes announced today that it appointed Aditya Khosla to its leadership team as the company’s chief technology officer. The Cambridge, Massachusetts–based developer of artificial intelligence-based precision medicine for gastroenterology also added Khosla to its board of directors. “We are thrilled to welcome Dr. Khosla to the Iterative Scopes team,” founder and CEO Jonathan Ng […]
Tandem Diabetes Care adds two new members to its board
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it appointed two new independent members to its board of directors. Myoung Cha and Joao Malagueira have been named to the San Diego-based automated insulin delivery technology developer’s board, effective yesterday, June 15, 2022. Get the full story at our sister site, Drug Delivery Business News.
Owen Mumford appoints new director of R&D
Owen Mumford announced today that it appointed Bal Johal as its director of research and development, effective next month. Johal will become the director of R&D for the Woodstock, United Kingdom-based developer of medical devices, including the Aidaptus auto-injector, on July 4, 2022. Get the full story at our sister site, Drug Delivery Business News.
